153
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Antiadipogenic activity of isohamnetin 3-O-β-D-glucopyranoside from Salicornia herbacea

&
Pages 907-911 | Received 07 Feb 2012, Accepted 24 Feb 2012, Published online: 17 Sep 2012

References

  • Han, S.K., Kim, S.M., Pyo, B.S. Antioxidative effect of glasswort (Salicornia herbacea L.) on the lipid oxidation of pork. Korean J Food Sci Anl Resour 2003, 23, 46–49.
  • Greenway, H., Munns, R. Mechanisms of salt tolerance in nonhalophytes. Annu Rev Plant Physiol 1980, 31, 149–190.
  • Bang, M.A., Kim, H.A., Cho, Y.J. Hypoglycemic and antioxidant effect of dietary hamcho powder in streptozotocin-induced diabetic rats. J Korean Soc Food Sci Nutr 2002, 31, 840–846.
  • Kim, M.W. Effects of Salicornia herbacea L. supplementation on lipid peroxidation and mineral levels in streptozotocin-induced diabetic rats. Korean J Nutr 2007, 40, 403–412.
  • Seo, Y., Lee, H.J., Kim, Y.A., Park, K.E. Antioxidative effect of glasswort (Salicornia herbacea) extract from Daebudo. Proceeding of Current Biotechnology and Bioengineering 2004, 10, 1–7.
  • Im, S.A., Kim, G.W., Lee, C.K. Immunomodulatory activity of Salicornia herbacea L. components. Nat Prod Sci 2003, 9, 273–277.
  • Lee, K.Y., Lee, M.H., Chang, I.Y., Yoon, S.P., Lim, D.Y., Jeon, Y.J. Macrophage activation by polysaccharide fraction isolated from Salicornia herbacea. J Ethnopharmacol 2006, 103, 372–378.
  • Park, S.H., Kim, K.S. Isolation and identification of antioxidant flavonoids from Salicornia herbacea L. J Korean Soc Appl Biol Chem 2004, 47, 120–123.
  • Kong, C.S., Kim, Y.A., Kim, M.M., Park, J.S., Kim, J.A., Kim, S.K., Lee, B.J., Nam, T.J., Seo, Y. Flavonoid glycosides isolated from Salicornia herbacea inhibit matrix metalloproteinase in HT1080 cells. Toxicol In Vitro 2008, 22, 1742–1748.
  • Yun, J.W. Possible anti-obesity therapeutics from nature–a review. Phytochemistry 2010, 71, 1625–1641.
  • Kong, C.S., Kim, J.A., Eom, T.K., Kim, S.K. Phosphorylated glucosamine inhibits adipogenesis in 3T3-L1 adipocytes. J Nutr Biochem 2010, 21, 438–443.
  • Fryer, L.G., Carling, D. AMP-activated protein kinase and the metabolic syndrome. Biochem Soc Trans 2005, 33, 362–366.
  • Luo, Z., Saha, A.K., Xiang, X., Ruderman, N.B. AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 2005, 26, 69–76.
  • Song, X.M., Fiedler, M., Galuska, D., Ryder, J.W., Fernström, M., Chibalin, A.V., Wallberg-Henriksson, H., Zierath, J.R. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 2002, 45, 56–65.
  • Meisse, D., Van de Casteele, M., Beauloye, C., Hainault, I., Kefas, B.A., Rider, M.H., Foufelle, F., Hue, L. Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FEBS Lett 2002, 526, 38–42.
  • Lee, W.J., Koh, E.H., Won, J.C., Kim, M.S., Park, J.Y., Lee, K.U. Obesity: the role of hypothalamic AMP-activated protein kinase in body weight regulation. Int J Biochem Cell Biol 2005, 37, 2254–2259.
  • Chien, P.J., Chien, Y.C., Lu, S.C., Sheu, F. Dietary flavonoids suppress adipogenesis in 3T3-L1 preadipocytes. J Food Drug Anal 2005, 13, 168–175.
  • Modhizuki, M., Fasegawa, N. Effects of green tea catechin-induced lipolysis on cytosol glycerol content in differentiated 3T3-L1 cells. Phytother Res 2004, 18, 945–946.
  • Hidalgo, M., Eckhardt, S.G. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001, 93, 178–193.
  • Rice-Evans, C.A., Miller, N.J., Paganga, G. Antioxidant properties of phenolic compounds. Trends Plant Sci 1997, 2, 152–159.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.